GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins Scientific SE (OTCPK:ERFSF) » Definitions » ROE %

Eurofins Scientific SE (Eurofins Scientific SE) ROE % : 6.32% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Eurofins Scientific SE ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Eurofins Scientific SE's annualized net income for the quarter that ended in Dec. 2023 was $346 Mil. Eurofins Scientific SE's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $5,477 Mil. Therefore, Eurofins Scientific SE's annualized ROE % for the quarter that ended in Dec. 2023 was 6.32%.

The historical rank and industry rank for Eurofins Scientific SE's ROE % or its related term are showing as below:

ERFSF' s ROE % Range Over the Past 10 Years
Min: 6.26   Med: 11.88   Max: 18.77
Current: 6.26

During the past 13 years, Eurofins Scientific SE's highest ROE % was 18.77%. The lowest was 6.26%. And the median was 11.88%.

ERFSF's ROE % is ranked better than
66.51% of 218 companies
in the Medical Diagnostics & Research industry
Industry Median: -6.13 vs ERFSF: 6.26

Eurofins Scientific SE ROE % Historical Data

The historical data trend for Eurofins Scientific SE's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins Scientific SE ROE % Chart

Eurofins Scientific SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.01 17.17 18.16 12.53 6.38

Eurofins Scientific SE Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.32 12.82 12.69 6.26 6.32

Competitive Comparison of Eurofins Scientific SE's ROE %

For the Diagnostics & Research subindustry, Eurofins Scientific SE's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurofins Scientific SE's ROE % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's ROE % distribution charts can be found below:

* The bar in red indicates where Eurofins Scientific SE's ROE % falls into.



Eurofins Scientific SE ROE % Calculation

Eurofins Scientific SE's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=338.277/( (5065.784+5537.077)/ 2 )
=338.277/5301.4305
=6.38 %

Eurofins Scientific SE's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Jun. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=346.128/( (5417.335+5537.077)/ 2 )
=346.128/5477.206
=6.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Eurofins Scientific SE  (OTCPK:ERFSF) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=346.128/5477.206
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(346.128 / 7208.506)*(7208.506 / 11526.406)*(11526.406 / 5477.206)
=Net Margin %*Asset Turnover*Equity Multiplier
=4.8 %*0.6254*2.1044
=ROA %*Equity Multiplier
=3 %*2.1044
=6.32 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=346.128/5477.206
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (346.128 / 444.492) * (444.492 / 479.172) * (479.172 / 7208.506) * (7208.506 / 11526.406) * (11526.406 / 5477.206)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7787 * 0.9276 * 6.65 % * 0.6254 * 2.1044
=6.32 %

Note: The net income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Eurofins Scientific SE ROE % Related Terms

Thank you for viewing the detailed overview of Eurofins Scientific SE's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Eurofins Scientific SE (Eurofins Scientific SE) Business Description

Traded in Other Exchanges
Address
23 Val Fleuri, Luxembourg, LUX, L-1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its main business activities are food and environmental testing, biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.